Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-208535
Filing Date
2012-05-03
Accepted
2012-05-03 16:18:11
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d336381d10q.htm 10-Q 512521
2 EXHIBIT 31.1 d336381dex311.htm EX-31.1 6147
3 EXHIBIT 31.2 d336381dex312.htm EX-31.2 6141
4 EXHIBIT 32.1 d336381dex321.htm EX-32.1 2580
5 EXHIBIT 32.2 d336381dex322.htm EX-32.2 2558
  Complete submission text file 0001193125-12-208535.txt   1758579

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ogxi-20120331.xml EX-101.INS 199469
7 XBRL TAXONOMY EXTENSION SCHEMA ogxi-20120331.xsd EX-101.SCH 9940
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ogxi-20120331_cal.xml EX-101.CAL 27885
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ogxi-20120331_lab.xml EX-101.LAB 94580
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ogxi-20120331_pre.xml EX-101.PRE 56098
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 033-80623 | Film No.: 12809940
SIC: 2835 In Vitro & In Vivo Diagnostic Substances